Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Derek, Rinchuse"'
Autor:
Muath, Abdeen, Urwat Til, Vusqa, Palash, Asawa, Kiley, Felton, Derek, Rinchuse, Cyrus, Khan, Yazan, Samhouri, John, Lister
Publikováno v:
Anti-Cancer Drugs. 33:1167-1170
Venetoclax, a highly selective Bcl-2 inhibitor, is an orally bioavailable drug that has been approved as first-line therapy for chronic lymphocytic leukemia (CLL) in combination with obinutuzumab, as well as monotherapy in the setting of relapsed CLL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0692fad4c51f2b8314fc09fde75108cf
https://doi.org/10.1097/cad.0000000000001350
https://doi.org/10.1097/cad.0000000000001350
Autor:
Abdeen, Muath, Vusqa, Urwat Til, Asawa, Palash, Felton, Kiley, Rinchuse, Derek, Khan, Cyrus, Samhouri, Yazan, Lister, John
Publikováno v:
Anti-Cancer Drugs; Nov2022, Vol. 33 Issue 10, p1167-1170, 4p